Clinical Trials on Human Papilloma Virus
Total 23987 results
-
Vancouver Infectious Diseases CentreUnknownDrug Use | Human Immunodeficiency Virus I InfectionCanada
-
Université Catholique de LouvainCliniques universitaires Saint-Luc- Université Catholique de LouvainCompletedHuman Immunodeficiency Virus I InfectionBelgium
-
Columbia UniversityCompletedHIV (Human Immunodeficiency Virus)United States
-
Huntridge Family ClinicUnknownExposure to Human Immunodeficiency Virus (Event)United States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusArgentina
-
ViiV HealthcareCompletedInfection, Human Immunodeficiency VirusUnited States, Spain, Peru, Romania, Colombia, South Africa, Germany, Russian Federation, Argentina, Mexico
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency Virus IGermany, Spain, France, Australia, United States, Canada, United Kingdom, Italy, Russian Federation
-
ViiV HealthcareGlaxoSmithKlineTerminatedInfection, Human Immunodeficiency VirusUnited States, France, Germany, Canada, Spain, United Kingdom, Mexico, Italy, Argentina, Chile, South Africa, Poland
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus IUnited States, Puerto Rico
-
Columbia UniversityMinistry of Health, SwazilandCompleted
-
Bristol-Myers SquibbMedarexCompletedHuman Immunodeficiency Virus (HIV)United States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusSpain, France, Germany, United States, Italy, Romania, Russian Federation, Switzerland, Puerto Rico
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited Kingdom
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
Mills Clinical ResearchViiV HealthcareUnknownInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompleted
-
GlaxoSmithKlineTerminatedInfection, Human Immunodeficiency VirusUnited States
-
GlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
GlaxoSmithKlineTerminatedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineNo longer availableInfection, Human Immunodeficiency VirusBelgium, Russian Federation, Italy, South Africa, Argentina, Switzerland, Poland
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States, France, Spain, Canada, Italy
-
Janssen PharmaceuticaWithdrawn
-
ViiV HealthcareGlaxoSmithKlineWithdrawnInfection, Human Immunodeficiency Virus IUnited States
-
ViiV HealthcareCompletedInfection, Human Immunodeficiency VirusUnited States
-
Tibotec Pharmaceuticals, IrelandCompletedHuman Immunodeficiency Virus Type 1United States, France, United Kingdom, China, Germany, South Africa, Russian Federation, Argentina, Brazil, Puerto Rico, Austria, Thailand, Mexico, Uganda
-
ViiV HealthcareGlaxoSmithKlineWithdrawnInfection, Human Immunodeficiency VirusUnited States
-
Tibotec Pharmaceuticals, IrelandTibotec Pharmaceutical LimitedCompletedHuman Immunodeficiency Virus 1South Africa, Argentina, Brazil, India, Kenya
-
Tibotec, IncTibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USACompletedHuman Immunodeficiency Virus (HIV)United States, Puerto Rico
-
Janssen-Cilag S.p.A.CompletedHuman Immunodeficiency Virus; HIV
-
Georgetown UniversityGlaxoSmithKlineCompletedHuman Immunodeficiency Virus InfectionsUnited States
-
Tibotec Pharmaceuticals, IrelandCompletedHuman Immunodeficiency Virus Type 1Germany
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States, Spain, France, United Kingdom, Chile, Brazil, Italy, Portugal
-
Nova Southeastern UniversityNational Institute of Mental Health (NIMH)CompletedHuman Immunodeficiency Virus I InfectionUnited States
-
ViiV HealthcarePfizerCompletedHuman Immunodeficiency Virus-1United States, Spain, Germany
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfections, Human Immunodeficiency Virus and HerpesviridaeUnited States
-
GlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
GlaxoSmithKlineShionogiCompletedHealthy Subjects | Infection, Human Immunodeficiency VirusUnited States
-
Bristol-Myers SquibbCompleted
-
University of MiamiNational Institute on Minority Health and Health Disparities (NIMHD)CompletedHepatitis C | ColoRectal Cancer | Human Immunodeficiency Virus | Human PapillomavirusUnited States
-
Hualan Biological Bacterin Co. Ltd.Henan Center for Disease Control and PreventionCompleted
-
Emory UniversityCompleted
-
G & W Laboratories Inc.Alquest; SMART Biotech LtdCompletedHepatitis C | Human Immunodeficiency Virus InfectionUnited States
-
Synermore Biologics Co., Ltd.inVentiv Health ClinicalCompleted
-
Sanofi Pasteur, a Sanofi CompanyRecruitingHealthy Volunteers | Respiratory Syncytial Virus Infection | Human MetapneumovirusUnited States, Puerto Rico
-
Indiana UniversityCompletedInfluenza Vaccines | Human Papillomavirus Vaccines | Attitude to Health
-
Janssen-Cilag International NVCompletedHuman Immunodeficiency Virus (HIV) Infections | Acquired Immunodeficiency Syndrome (AIDS) VirusFrance, United Kingdom, Belgium, Germany, Spain, Switzerland, Denmark, Israel, Austria, Poland, Hungary, Sweden, Ireland